Valuation : Optiscan Imaging Limited

Market Cap 157M 112M 96.79M 91.64M 83.07M 156M 10.73B 1.09B 419M 5.46B 422M 413M 17.25B P/E 2025
-14.5x
P/E 2026 -17.1x
Enterprise Value 144M 103M 88.75M 84.03M 76.17M 143M 9.84B 998M 384M 5.01B 387M 378M 15.82B EV / Sales 2025
23.8x
EV / Sales 2026 31.1x
Free-Float
36.31%
Yield 2025 *
-
Yield 2026 -
1 day-3.23%
Current month-3.23%
1 month-18.92%
3 months+20.00%
6 months+59.57%
Current year+50.00%
1 week 0.14
Extreme 0.135
0.16
1 month 0.14
Extreme 0.135
0.18
Current year 0.08
Extreme 0.08
0.2
1 year 0.08
Extreme 0.08
0.2
3 years 0.07
Extreme 0.071
0.26
5 years 0.07
Extreme 0.071
0.26
10 years 0.01
Extreme 0.013
0.47
Manager TitleAgeSince
Chief Executive Officer - 12/12/2021
Director of Finance/CFO - 30/03/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member - 09/02/2021
Chairman - 18/04/2021
Director/Board Member - 05/05/2021
Date Insider Type Main position Quantity % Market Cap. Importance
09/09/26 Exercice

Director

230,502 0.0221%
09/09/26 Exercice

Director

-230,502 0.0221%
07/09/26 Exercice

Chairman

-419,094 0.0401%
Change 5-day change 1-year change 3-year change Capi.($)
-3.23%0.00%+76.47%+92.31% 112M
+0.73%-5.04%-31.76%-2.35% 12.56B
-2.07%-2.38%+11.19%+9.93% 4.13B
-3.46%-4.65%-46.75%-58.46% 1.21B
-2.76%-5.97%-44.19%-45.09% 1.07B
+0.43%-1.47%+15.36%+88.23% 1.05B
-1.47%-7.83% - - 954M
-2.35%-6.69%-41.36% - 953M
-4.21%-3.00%+27.85%+92.66% 489M
+1.23%+10.18%+60.19% - 330M
Average -1.72%-3.57%+3.00%+25.32% 2.29B
Weighted average by Cap. -0.51%-4.51%-19.98%+1.99%

Financials

2025 2026
Net sales 3.72M 2.67M 2.3M 2.18M 1.98M 3.71M 255M 25.88M 9.95M 130M 10.03M 9.81M 410M 3.61M 2.59M 2.23M 2.11M 1.92M 3.6M 248M 25.11M 9.66M 126M 9.73M 9.52M 398M
Net income -6.31M -4.53M -3.9M -3.69M -3.35M -6.28M -432M -43.86M -16.87M -220M -17M -16.63M -695M -6.99M -5.01M -4.32M -4.09M -3.71M -6.95M -479M -48.55M -18.67M -244M -18.82M -18.4M -770M
Net Debt -3.07M -2.2M -1.9M -1.8M -1.63M -3.06M -210M -21.34M -8.21M -107M -8.27M -8.09M -338M -13.01M -9.33M -8.04M -7.61M -6.9M -12.94M -891M -90.39M -34.76M -453M -35.04M -34.27M -1.43B
Logo Optiscan Imaging Limited
Optiscan Imaging Limited is a commercial stage medical technology company. It creates a suite of digital pathology and precision surgery hardware and software solutions that enable live optical biopsy for life sciences, diagnostic and surgical applications. It is engaged in development, manufacturing, and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Its technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level. Its products include InVue, InForm, InVivage, ViewnVivo and InSpecta. ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand. InVivage is an intra-oral digital endomicroscope.
Employees
9
Date Price Change Volume
11/09/26 A$0.1500 -3.23% 463,843
10/09/26 A$0.1550 +3.33% 61,808
09/09/26 A$0.1500 0.00% 5,854
08/09/26 A$0.1500 0.00% 376,399
07/09/26 A$0.1500 0.00% 33,955
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!